Equity Research Consumer & Cannabis Managing Director Aaron Grey Says Impact It Ranges Upoward For Companies In My Coverage Up To $150M; Benefit Will Take Care Of Debt, Will Come From M&A Or Capex; Depending; Case-By-Case Basis On How They Use Proceeds
Portfolio Pulse from Benzinga Newsdesk
Aaron Grey, Managing Director of Equity Research Consumer & Cannabis, suggests that companies in his coverage could see an upward impact of up to $150M. This benefit, which could address debt, will stem from M&A or capital expenditures, depending on how proceeds are used.
October 08, 2024 | 3:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MSOS, a cannabis-focused ETF, may benefit from Aaron Grey's projection of up to $150M impact for companies in his coverage. The impact will depend on M&A or capex activities and how proceeds are utilized.
MSOS, being a cannabis-focused ETF, is likely to include companies that Aaron Grey covers. The potential $150M impact from M&A or capex could positively affect the ETF's holdings, leading to a positive short-term price movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80